Micron’s stock sentiment is weak. Here’s what could flip the script.
Micron shares have shed most of their 2024 gains, but memory pricing could improve in the coming months, Citi says.
Shohei Ohtani, the first to ever achieve 50/50, is the 352nd highest-paid player in MLB this season
That’s in part because most of his $700 million contract is deferred. Still, his stats this season are worth over $50 million to his team.
Why Constellation Energy and Vistra shares are building on massive gains
Constellation has a new nuclear-power deal with Microsoft. Both Constellation and Vistra shares have more than doubled this year on optimism for data-center power deals.
Why Fed bets were so out of whack: Waller explains what put him ‘over the edge’ for a jumbo rate cut
Inflation might actually fall too far, Fed governor says.
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.
Social Security’s COLA provides invaluable protection
Recent inflation spike — and moderation — underscores its importance
‘Powell delivered the stock market to the Promised Land.’ Why the S&P 500 could soar past 6,000 by year-end.
Yardeni: Odds of a 1990s-like market boom have increased after Fed rate-cut.
Small-cap stocks post longest rally since 2021 after Fed rate cut. What’s next?
Small-cap stocks just saw their longest winning streak in three and a half years, after the Federal Reserve recalibrated its monetary policy with a big...
Four things you need to know about Medicare drug costs and coverage in 2025
With Medicare prescription-drug benefits on the brink of a shake-up, enrollees who hope to minimize their costs at the pharmacy counter next year need to...